vs
Side-by-side financial comparison of Commercial Bancgroup, Inc. (CBK) and FONAR CORP (FONR). Click either name above to swap in a different company.
FONAR CORP is the larger business by last-quarter revenue ($25.5M vs $23.1M, roughly 1.1× Commercial Bancgroup, Inc.). Commercial Bancgroup, Inc. runs the higher net margin — 41.3% vs 8.0%, a 33.3% gap on every dollar of revenue.
Commercial Bancgroup, Inc.CBKEarnings & Financial Report
Commercial Bancgroup, Inc. operates as a U.S. regional bank holding company that provides a full suite of retail and commercial banking products and services to individual consumers, small and medium-sized businesses, and local institutional clients. Its core offerings include deposit accounts, lending solutions, wealth management, and tailored financial advisory services for regional markets.
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
CBK vs FONR — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $23.1M | $25.5M |
| Net Profit | $9.5M | $2.1M |
| Gross Margin | — | — |
| Operating Margin | — | 13.5% |
| Net Margin | 41.3% | 8.0% |
| Revenue YoY | — | 2.4% |
| Net Profit YoY | 9.7% | 4.7% |
| EPS (diluted) | $0.69 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $23.1M | — | ||
| Q4 25 | $23.5M | $25.5M | ||
| Q3 25 | $22.8M | $26.0M | ||
| Q2 25 | — | $27.3M | ||
| Q1 25 | — | $27.2M | ||
| Q4 24 | — | $24.9M | ||
| Q3 24 | — | $25.0M | ||
| Q2 24 | — | $25.9M |
| Q1 26 | $9.5M | — | ||
| Q4 25 | $9.9M | $2.1M | ||
| Q3 25 | $9.5M | $2.3M | ||
| Q2 25 | — | $729.3K | ||
| Q1 25 | — | $2.5M | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | — | $830.4K |
| Q1 26 | — | — | ||
| Q4 25 | — | 13.5% | ||
| Q3 25 | 53.8% | 14.1% | ||
| Q2 25 | — | 5.3% | ||
| Q1 25 | — | 15.2% | ||
| Q4 24 | — | 11.9% | ||
| Q3 24 | — | 21.0% | ||
| Q2 24 | — | 7.4% |
| Q1 26 | 41.3% | — | ||
| Q4 25 | 42.2% | 8.0% | ||
| Q3 25 | 41.4% | 8.7% | ||
| Q2 25 | — | 2.7% | ||
| Q1 25 | — | 9.2% | ||
| Q4 24 | — | 7.9% | ||
| Q3 24 | — | 12.6% | ||
| Q2 24 | — | 3.2% |
| Q1 26 | $0.69 | — | ||
| Q4 25 | $0.72 | — | ||
| Q3 25 | $0.77 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $121.0K |
| Total DebtLower is stronger | $118.2M | — |
| Stockholders' EquityBook value | — | $176.9M |
| Total Assets | $2.3B | $217.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $121.0K | ||
| Q3 25 | $154.8M | $122.0K | ||
| Q2 25 | — | $56.5M | ||
| Q1 25 | — | $123.0K | ||
| Q4 24 | — | $121.0K | ||
| Q3 24 | — | $136.0K | ||
| Q2 24 | — | $56.5M |
| Q1 26 | $118.2M | — | ||
| Q4 25 | $166.8M | — | ||
| Q3 25 | $100.1M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $66.9K |
| Q1 26 | — | — | ||
| Q4 25 | — | $176.9M | ||
| Q3 25 | $245.2M | $174.9M | ||
| Q2 25 | — | $172.6M | ||
| Q1 25 | — | $171.9M | ||
| Q4 24 | — | $169.8M | ||
| Q3 24 | — | $168.7M | ||
| Q2 24 | — | $166.0M |
| Q1 26 | $2.3B | — | ||
| Q4 25 | $2.3B | $217.2M | ||
| Q3 25 | $2.2B | $218.4M | ||
| Q2 25 | — | $216.9M | ||
| Q1 25 | — | $214.9M | ||
| Q4 24 | — | $208.0M | ||
| Q3 24 | — | $212.3M | ||
| Q2 24 | — | $214.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $171.0K |
| Free Cash FlowOCF − Capex | — | $-227.0K |
| FCF MarginFCF / Revenue | — | -0.9% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | — | 0.08× |
| TTM Free Cash FlowTrailing 4 quarters | — | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $171.0K | ||
| Q3 25 | $28.0M | $1.7M | ||
| Q2 25 | — | $4.2M | ||
| Q1 25 | — | $3.1M | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $4.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-227.0K | ||
| Q3 25 | $26.5M | $-177.0K | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $2.6M | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | — | $-148.0K | ||
| Q2 24 | — | $4.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | -0.9% | ||
| Q3 25 | 115.8% | -0.7% | ||
| Q2 25 | — | 13.1% | ||
| Q1 25 | — | 9.4% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | — | -0.6% | ||
| Q2 24 | — | 16.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.6% | ||
| Q3 25 | 6.7% | 7.2% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 7.2% | ||
| Q2 24 | — | 1.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | 2.96× | 0.75× | ||
| Q2 25 | — | 5.79× | ||
| Q1 25 | — | 1.26× | ||
| Q4 24 | — | 1.14× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 5.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBK
| Net Interest Income | $20.5M | 89% |
| Noninterest Income | $2.6M | 11% |
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
